| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MI-1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.003 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.17 | 0.003 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.003 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |